<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Modern Care Journal</title>
<title_fa>مراقبت های نوین</title_fa>
<short_title>Mod Care J</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mcj.bums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn></journal_id_issn>
<journal_id_issn_online>2423-7876</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>doi</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1386</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2008</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<volume>5</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa>بررسی تغییرات کراتومتری و عیوب انکساری در بیماران مبتلا به ناخنک قبل و بعد از تزریق آمپول میتومایسین C</title_fa>
	<title>Assessment of keratometry changes and Refractive Errors in patients with Pterygium before and after injection of mitomycin C</title>
	<subject_fa></subject_fa>
	<subject>General </subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>Pterygium is the development of pinguecula that makes a mass of oval and palmy shape near limbus and its main treatment is surgery but due to some complications and high recurrence after syrgery, subconjunctival injection of mitomycin -C as a safe and effective treatment was detected in many researches so this study determine this purpose and prevelance in Birjand. &amp;nbsp; Materials and Methods: 30 eyes patients with pterygium referred to Vali- Asr of Birjand Hospital received 0.1 ml of 0.2 mg/ml mitomycin -subconjunectively injected into the body of the pterygium. After injection, patients were followed up at first week 3-5 months after pterygium injection. Patients were examimed at all visits for conjunctiva erythematic, epithehial defects and pterygium size reductive (regression of pterygium ). Data were gathered via 3 questionnaires. Then they were analyzed by SPSS and paired T test.(&amp;alpha;=0.05) &amp;nbsp; Results: The complications after sub. Conjuntive mitomycin- C injection were mild chemosis and lonf discomfort and redness in the site of injection for four days that were seen in six patients (20%). No toxicity of mitomycin- C were found the size of pterygium was reduced in ( mean 0.48 mm ) 83% of cases and in all cases there were not seen progression and the amount of Astigmatism reduced (mean 0.46 diopter) in 70% cases. &amp;nbsp; Conclusion: Subconjunctival injection of mitomycin- C is an effective treatment and reduces the size of pterygium as well as redness and astigmatism.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Pterygium,Mitomycin C,Subconjunctival</keyword>
	<start_page>44</start_page>
	<end_page>48</end_page>
	<web_url>http://mcj.bums.ac.ir/browse.php?a_code=A-10-1-417&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mohammad Hasan</first_name>
	<middle_name></middle_name>
	<last_name> Davari</last_name>
	<suffix></suffix>
	<first_name_fa>محمدحسین</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>داوری</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846004627</code>
	<orcid>10031947532846004627</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Assistant Professor, Department of Ophthalmology, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran</affiliation>
	<affiliation_fa>استادیار گروه آموزشی چشم پزشکی دانشکده پزشکی دانشگاه علوم پزشکی بیرجند</affiliation_fa>
	 </author>


	<author>
	<first_name>Sheida</first_name>
	<middle_name></middle_name>
	<last_name>Pejmankhah</last_name>
	<suffix></suffix>
	<first_name_fa>شیدا</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>پژمان‌خواه</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846004628</code>
	<orcid>10031947532846004628</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Instructor, Faculty of Nursing and Midwifery, Birjand University of Medical Sciences, Birjand, Iran.   Email:vojodhasti@yahoo.com</affiliation>
	<affiliation_fa>کارشناس ارشد پرستاری و عضو هیات علمی دانشکده پرستاری و مامایی دانشگاه علوم پزشکی بیرجند.  تلفن:4440550-0561   پست الکترونیک: vojodhasti@yahoo.com</affiliation_fa>
	 </author>


	<author>
	<first_name>Nooshin </first_name>
	<middle_name></middle_name>
	<last_name>Abdolah Challaki</last_name>
	<suffix></suffix>
	<first_name_fa>نوشین</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>عبداله چاهکی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846004629</code>
	<orcid>10031947532846004629</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>General Practitioner</affiliation>
	<affiliation_fa>پزشک عمومی</affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
